Phase II study of high-dose dexamethasone-based association in acute and delayed high-dose cisplatin-induced emesis--JCOG study 9413.

Thirty-three patients with lung cancer receiving 80 mg m(-2) cisplatin were treated with high-dose dexamethasone (32 mg m(-2) on days 1-3, 16 mg m(-2) on day 4 and 8 mg m(-2) on day 5) combined with granisetron on day 1 and metoclopramide on days 2-5. Twenty-eight (85%) patients had no nausea or vom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sekine, I., Nishiwaki, Y., Kakinuma, R., Kubota, K., Hojo, F., Matsumoto, T., Ohmatsu, H., Yokozaki, M., Goto, K., Miyamoto, T., Takafuji, J., Kodama, T.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1997
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2223781/
https://ncbi.nlm.nih.gov/pubmed/9218738
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados